3 news items
Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)
ATXI
FBIO
16 May 24
and regulations relating to fraud and abuse, false claims, transparency, health information privacy and security, and other healthcare laws and regulations
Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
ATXI
FBIO
15 May 24
to substantial regulatory scrutiny; the effects of current and future laws and regulations relating to fraud and abuse, false claims, transparency, health
Avenue Therapeutics Announces Reverse Stock Split
ATXI
FBIO
24 Apr 24
regulatory scrutiny; the effects of current and future laws and regulations relating to fraud and abuse, false claims, transparency, health information
- Prev
- 1
- Next